Sponsor Check › Sponsor group
One sponsor team, 37 deal companies · New York, NY
Grouped because: 20 shared people, 6 shared management entities, same business address (25 issuers), similar issuer names (34), same person name on both filings (1) · 2 issuers also list a director who sits on many unrelated issuers (not used to group) (automatic match from the filings) · not the same sponsor?
Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Oct 16, 2026 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Orbimed is a sponsor group of 37 issuers that PartnerFacts links to one sponsor (shared people, shared management entity, similar issuer names, shared principal (person on 60+ issuers) at the same address or management entity, same business address, same person name on both filings; automatic match from the filings), filing 166 Form D filings between May 2009 and Oct 2026.
What this means One team, 37 deal companies, about 17 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.
Combined reported sold: $20.2B to 3,315 investors (latest filing per issuer). Industries as reported: Pooled Investment Fund (35), Biotechnology (1), "Other" (1). Issuers are based in NY (28), Cayman Islands (as filed: E9) (6), Virgin Islands, British (as filed: D8) (1), Israel (as filed: L3) (1) and 1 more.
What this means $20.2B raised across the group, about $6.09M per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.
Principal people: Carl L. Gordon (27 issuers, executive officer, director, and promoter), Sven H. Borho (27 issuers, executive officer, director, and promoter), W. Carter Neild (25 issuers, executive officer, director, and promoter), OrbiMed Advisors LLC (22 issuers, executive officer and promoter, entity), Jonathan T. Silverstein (19 issuers, executive officer, director, and promoter) and 66 more.
What this means The person on the most companies is usually the one running the show; their page lists every deal.
Activity: 0 new offerings in the last 12 months; latest filing Oct 16, 2026.
What this means No new raise filed in the past year.
Adviser registration (Form ADV) on record: ORBIMED ADVISORS LLC.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — none found.
What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared the newest 50 of 166 public filings for Orbimed and found 30 differences, 11 worth asking the sponsor about: Amount sold went down between filings; Orbimed includes 5 deals that stopped filing before reaching their target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Orbimed has not run yet — it is joining a line of 54,845 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Orbimed..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No comparisons published
No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.
30 differences found between the filings for Orbimed — 11 worth asking about (compared the newest 50 of 166 filings on Oct 24, 2026; older filings not covered)
United States Bankruptcy Court, N.D. New York docket "Megan Dow" filed Oct 13, 2010, closed Jun 5, 2012. Megan Dow (listed on the same filings) is listed as Debtor ("Megan Dow"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Apr 14, 2022 filing says $51,259,670 sold; the Apr 14, 2023 Form D/A says $44,088,402 sold — $7,171,268 less.
What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.
The Apr 14, 2022 filing says $82,237,734 sold; the Apr 14, 2023 Form D/A says $81,529,342 sold — $708,392 less.
What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.
OrbiMed Private Investments VIII, LP (last filing Aug 27, 2020; $0 sold of $1,400,000,000); OrbiMed Private Investments VII, LP (last filing Jan 30, 2018; $0 sold of $1,000,000,000); OrbiMed Israel Partners II, L.P. (last filing Dec 14, 2015; $0 sold of $300,000,000); OrbiMed Private Investments VI, LP (last filing Sep 15, 2015; $0 sold of $950,000,000); OrbiMed Asia Partners II, LP (last filing Aug 15, 2013; $0 sold of $300,000,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
UBS Switzerland AG is listed as receiving sales compensation on 3 filings (Sep 29, 2025 to Oct 16, 2026) with no FINRA CRD number given.
What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.
UBS Switzerland AG is listed as receiving sales compensation on 3 filings (Sep 29, 2025 to Oct 16, 2026) with no FINRA CRD number given.
What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.
The address on file, C/O Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman, Cayman Islands (as filed: E9), is used by 222 issuers in our index across 112 sponsor groups; 220 are outside this group. It is on our registered-agent / shared-office list (registered agent / corporate services / fund administrator).
What this means Many unrelated companies file from this address. Often a registered agent or a fund administrator; sometimes a shared office. Ask where the team actually works.
The address on file, 330 Madison Avenue, Suite 3010, New York, NY, is used by 18 issuers in our index across 7 sponsor groups; 16 are outside this group. It is on our registered-agent / shared-office list (18 issuers in 10 unrelated clusters).
What this means Many unrelated companies file from this address. Often a registered agent or a fund administrator; sometimes a shared office. Ask where the team actually works.
The address on file, C/O Intertrust Corp. Svcs. (Cayman) Ltd., One Nexus Way, Camana Bay, Grand Cayman, Cayman Islands (as filed: E9), is used by 19 issuers in our index across 6 sponsor groups; 18 are outside this group. It is on our registered-agent / shared-office list (registered agent / corporate services / fund administrator).
What this means Many unrelated companies file from this address. Often a registered agent or a fund administrator; sometimes a shared office. Ask where the team actually works.
The filing says the first sale was Feb 15, 2024. The Form D was filed Jul 5, 2024 — 141 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 126 days past that.
What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.
No amendment in the last 12 months on an offering that may still be open — Worldwide Healthcare Partners LLC (latest filing Aug 18, 2025) · No amendment in the last 12 months on an offering that may still be open — Worldwide Healthcare Partners International Ltd. (latest filing Aug 18, 2025) · No amendment in the last 12 months on an offering that may still be open — Emerging Markets Healthcare Partners LLC (latest filing Aug 18, 2025) · No amendment in the last 12 months on an offering that may still be open — Emerging Markets Healthcare Partners International Ltd. (latest filing Aug 18, 2025) · No amendment in the last 12 months on an offering that may still be open — OrbiMed Royalty & Credit Opportunities V, LP (latest filing May 6, 2025) · and 8 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Sven H. Borho is no longer listed on the Oct 16, 2026 amendment — OrbiMed Asia Partners VI, L.P. · Sven H. Borho is no longer listed on the Oct 16, 2026 amendment — OrbiMed Private Investments X, LP · Carlos Manuel Godoy is no longer listed on the Jun 7, 2024 amendment — Worldwide Healthcare Partners International Ltd. · Carlos Manuel Godoy is no longer listed on the Jun 7, 2024 amendment — Emerging Markets Healthcare Partners International Ltd. · Jonathan T. Silverstein is no longer listed on the Dec 9, 2022 amendment — OrbiMed Genesis Fund, L.P.
What this means People leave; the issuer lists only current officers, directors and promoters. Ask why and who replaced them.
OrbiMed Advisors LLC's role changed at OrbiMed Genesis Fund, L.P.: promoter → executive officer, promoter · OrbiMed Advisors LLC's role changed at OrbiMed Genesis Fund, L.P.: executive officer, promoter → promoter · Samuel D. Isaly's role changed at Worldwide Healthcare Partners International Ltd.: director, promoter → executive officer, director · Carl L. Gordon's role changed at OrbiMed Partners II, L.P.: executive officer, promoter → executive officer · OrbiMed Advisors LLC's role changed at OrbiMed Partners II, L.P.: executive officer → executive officer, promoter · and 8 more
What this means Roles on Form D are self-reported. Ask who runs the company today.
The May 28, 2026 filing says $850,000,000 offered; the Oct 16, 2026 Form D/A says $1,045,599,648.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Apr 30, 2026 filing says $1,750,000,000 offered; the Oct 16, 2026 Form D/A says $1,921,099,472.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Jul 14, 2022 filing says $350,000,000 offered; the Dec 16, 2022 Form D/A says $500,000,000.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
OrbiMed Capital GP X, LP is written 2 different ways on the filings · OrbiMed ROF V LLC is written 2 different ways on the filings · Carl L. Gordon is written 2 different ways on the filings · David G. Wang is written 2 different ways on the filings · Jonathan T. Silverstein is written 2 different ways on the filings · and 2 more
What this means Middle names and suffixes come and go on these forms. Check full legal names against your documents.
"$1 - $5,000,000" (Apr 14, 2020); then "Decline to Disclose" (Apr 14, 2021).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
"$25,000,001 - $50,000,000" (Apr 14, 2020); then "Decline to Disclose" (Apr 14, 2021).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
"$1 - $5,000,000" (Apr 14, 2020); then "Decline to Disclose" (Apr 14, 2021).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
CIK 1796304 (first filed Dec 12, 2019, New York, NY); CIK 1808344 (first filed Apr 14, 2020, George Town, Grand Cayman, Cayman Islands (as filed: E9)).
What this means Two legal entities with one name can make it unclear which one you invested in. Match the CIK and the SEC file number on your documents, not just the name.
CIK 1808097 (first filed Apr 14, 2020, New York, NY); CIK 1808094 (first filed Apr 14, 2020, George Town, Grand Cayman, Cayman Islands (as filed: E9)).
What this means Two legal entities with one name can make it unclear which one you invested in. Match the CIK and the SEC file number on your documents, not just the name.
CIK 1588471 (first filed Oct 15, 2013, Grand Cayman, Cayman Islands (as filed: E9)); CIK 1613540 (first filed Jul 14, 2014, New York, NY).
What this means Two legal entities with one name can make it unclear which one you invested in. Match the CIK and the SEC file number on your documents, not just the name.
CIK 915444 (first filed Mar 12, 2010, New York, NY); CIK 1459984 (first filed Mar 12, 2010, Road Town, Tortola, Virgin Islands, British (as filed: D8)).
What this means Two legal entities with one name can make it unclear which one you invested in. Match the CIK and the SEC file number on your documents, not just the name.
Address on file is a registered agent / shared office — OrbiMed Partners, Ltd. · Address on file is a registered agent / shared office — OrbiMed Genesis Fund, Ltd. · Address on file is a registered agent / shared office — Worldwide Healthcare Partners LLC · Address on file is a registered agent / shared office — Worldwide Healthcare Partners International Ltd. · Address on file is a registered agent / shared office — Emerging Markets Healthcare Partners LLC · and 2 more
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business operates.
Delaware (21), Cayman Islands (13), E9 (1), Virgin Islands, British (1), Israel (1) — out of 37 member issuers. The odd ones out: CADUCEUS ASIA PARTNERS LP (E9); OrbiMed Partners, Ltd. (Virgin Islands, British); OrbiMed Israel Partners Limited Partnership (Israel); OrbiMed Asia Partners II, LP (Cayman Islands); OrbiMed Global Healthcare Fund, Ltd. (Cayman Islands); OrbiMed Israel Partners II, L.P. (Cayman Islands).
What this means Sponsors often form each deal company in Delaware or Wyoming no matter where the property is. A mix is common; it just tells you which state's rules each company lives under.
NY (28), Cayman Islands (as filed: E9) (6), Virgin Islands, British (as filed: D8) (1), Israel (as filed: L3) (1), IL (1). 9 members use a registered-agent or shared-office address: CADUCEUS ASIA PARTNERS LP (C/O Walkers Spv Ltd, Walker House 87 Mary Street, George Town, Cayman Islands (as filed: E9)); OrbiMed Partners, Ltd. (C/O Walkers Corporate (Bvi) Limited, 171 Main Street, P.O. Box 92, Road Town, Tortola, Virgin Islands, British (as filed: D8)); OrbiMed Global Healthcare Fund, Ltd. (C/O Intertrust Corp. Svcs. (Cayman) Ltd., One Nexus Way, Camana Bay, Grand Cayman, Cayman Islands (as filed: E9)); Emerging Markets Healthcare Partners LLC (330 Madison Avenue, Suite 3010, New York, NY).
What this means A registered agent's address is a mailbox, not where the team works. The other address is more likely the real office — ask which one is.
SEC records list prior names for this filer: Caduceus Capital II, L.P.. The current name on file is "OrbiMed Partners II, L.P.".
What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.
SEC records list prior names for this filer: Caduceus Capital, Ltd.; Caduceus Capital Ltd.; Caduceus Capital LTD. The current name on file is "OrbiMed Partners, Ltd.".
What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.
SEC records list prior names for this filer: SURMOUNT BIO, INC.. The current name on file is "VANQUA BIO, INC.".
What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 166 filings (work cap); older filings are not covered here. As of Oct 24, 2026.
11 of 41 offerings report sales commissions totalling $82,679,809; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Oct 16, 2026 D/A OrbiMed Private Investments X, LP File 021-559153 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the active investment period and a percentage tied to invested capital thereafter. | UBS Switzerland AG no CRD number reported MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BrokerCheck CRD 7691 ↗ | EDGAR ↗ |
| Oct 16, 2026 D/A OrbiMed Asia Partners VI, L.P. File 021-559156 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the active investment period and a percentage tied to invested capital thereafter. | UBS Switzerland AG no CRD number reported MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BrokerCheck CRD 7691 ↗ J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Jul 10, 2026 D/A OrbiMed Partners II, L.P. File 021-128771 | $30,915,209 (est.) | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | Far Hills Group, LLC BrokerCheck CRD 000032243 ↗ | EDGAR ↗ |
| Jul 10, 2026 D/A OrbiMed Partners, Ltd. File 021-129096 | $35,481,672 (est.) | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | Far Hills Group, LLC BrokerCheck CRD 000032243 ↗ | EDGAR ↗ |
| Apr 10, 2026 D/A OrbiMed Genesis Fund, Ltd. File 021-364900 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Dec 5, 2025 D/A OrbiMed Genesis Fund, L.P. File 021-355430 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Aug 18, 2025 D/A Emerging Markets Healthcare Partners LLC File 021-364968 | $0 | $0 | $0 Customary advisory fees will be paid by the Issuer to the Investment Manager as provided for in the Issuer's offering materials. | None listed on this filing | EDGAR ↗ |
| Aug 18, 2025 D/A Worldwide Healthcare Partners LLC File 021-364969 | $0 | $0 | $0 Customary advisory fees will be paid by the Issuer to the Investment Manager as provided for in the Issuer's offering materials. | None listed on this filing | EDGAR ↗ |
| Aug 18, 2025 D/A Emerging Markets Healthcare Partners International Ltd. File 021-374631 | $986 | $0 | $0 Customary advisory fees will be paid to the Investment Manager at the master fund level as provided for in the Issuer's offering materials. | Fairview Securities, Inc. BrokerCheck CRD 35703 ↗ via Fairview Securities, Inc. (CRD 35703 ↗) | EDGAR ↗ |
| Aug 18, 2025 D/A Worldwide Healthcare Partners International Ltd. File 021-374643 | $918 | $0 | $0 Customary advisory fees will be paid to the Investment Manager at the master fund level as provided for in the Issuer's offering materials. | Fairview Securities, Inc. BrokerCheck CRD 35703 ↗ via Fairview Securities, Inc. (CRD 35703 ↗) | EDGAR ↗ |
| May 6, 2025 D/A OrbiMed RCO V Offshore Feeder, LP File 021-529422 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| May 6, 2025 D/A OrbiMed Royalty & Credit Opportunities V, LP File 021-529419 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Jul 17, 2024 D Belenos Biosciences, Inc. File 021-519049 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 5, 2024 D VANQUA BIO, INC. File 021-517876 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 28, 2023 D/A OrbiMed Private Investments IX, LP File 021-443751 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services equal to a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | None listed on this filing | EDGAR ↗ |
| Apr 14, 2023 D/A OrbiMed New Horizons Fund, L.P. File 021-364898 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Apr 14, 2023 D/A OrbiMed New Horizons Fund, Ltd. File 021-364899 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Dec 16, 2022 D/A OrbiMed Royalty & Credit Opportunities IV, LP File 021-443752 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Dec 16, 2022 D/A OrbiMed RCO IV Offshore Feeder, LP File 021-452404 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Nov 28, 2022 D/A OrbiMed Asia Partners V, L.P. File 021-443753 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP and GPLTD will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ Wells Fargo Clearing Services, LLC BrokerCheck CRD 19616 ↗ Wells Fargo Advisors Financial Network, LLC BrokerCheck CRD 11025 ↗ | EDGAR ↗ |
| Sep 15, 2021 D VANQUA BIO, INC. File 021-413372 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 16, 2021 D/A OrbiMed Global Healthcare Fund, Ltd. File 021-204519 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Jul 16, 2021 D/A OrbiMed Global Healthcare Associates Fund, L.P. File 021-212193 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 16, 2021 D/A OrbiMed Global Healthcare Fund, L.P. File 021-220964 | $0 | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | None listed on this filing | EDGAR ↗ |
| Sep 2, 2020 D/A OrbiMed Asia Partners IV, L.P. File 021-362067 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the GPLP and GPLTD will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Aug 27, 2020 D OrbiMed Private Investments VIII, LP File 021-374300 | $0 | $0 | $0 An affiliate of the General Partner will receive a fee for management services equal to a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | None listed on this filing | EDGAR ↗ |
| Oct 7, 2019 D VANQUA BIO, INC. File 021-350518 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 3, 2019 D/A OrbiMed Royalty & Credit Opportunities III, LP File 021-331673 | $0 (est.) | $0 (est.) | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Jun 21, 2019 D/A Emerging Markets Healthcare Partners LLC File 021-341095 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 21, 2019 D/A Worldwide Healthcare Partners LLC File 021-341096 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 30, 2018 D OrbiMed Private Investments VII, LP File 021-304413 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | None listed on this filing | EDGAR ↗ |
| Sep 6, 2017 D/A OrbiMed Asia Partners III, L.P. File 021-281414 | $2,478,300 | $0 | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage based on invested capital thereafter. | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Jul 14, 2017 D/A OrbiMed Partners, L.P. File 021-91544-4N | $3,228,724 (est.) | $0 | $0 The fund charges a management fee that is described in the fund's offering documents. | Far Hills Group, LLC BrokerCheck CRD 32243 ↗ | EDGAR ↗ |
| Dec 14, 2015 D OrbiMed Israel Partners II, L.P. File 021-253036 | $0 | $0 | $0 (est.) An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | None listed on this filing | EDGAR ↗ |
| Sep 15, 2015 D OrbiMed Private Investments VI, LP File 021-247616 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | None listed on this filing | EDGAR ↗ |
| Feb 2, 2015 D OrbiMed Royalty Opportunities II, LP File 021-233267 | $1,500,000 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | Merrill Lynch, Pierce, Fenner & Smith Incorporated BrokerCheck CRD 7691 ↗ | EDGAR ↗ |
| Nov 5, 2013 D OrbiMed Private Investments V, LP File 021-205773 | $1,740,000 (est.) | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | Merrill Lynch, Pierce, Fenner & Smith Incorporated BrokerCheck CRD 7691 ↗ | EDGAR ↗ |
| Aug 15, 2013 D OrbiMed Asia Partners II, LP File 021-201444 | $0 (est.) | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter. | Merrill Lynch, Pierce, Fenner & Smith Incorporated BrokerCheck CRD 7691 ↗ | EDGAR ↗ |
| Apr 18, 2011 D OrbiMed Israel Partners Limited Partnership File 021-158558 | $1,830,000 (est.) | $0 | $0 (est.) An affiliate of the General Partner will receive an annual fee for management services. Amount to be paid, number of years to be paid and extent paid out of adjusted gross proceeds are unknown at this time | J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| Dec 30, 2009 D Caduceus Private Investments IV, LP File 021-137285 | $2,250,000 (est.) | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of the aggregate subscriptions of the Issuer's limited partners during the investment period, and a percentage of invested capital thereafter. | J.P. Morgan Securities Inc. BrokerCheck CRD 79 ↗ | EDGAR ↗ |
| May 12, 2009 D/A CADUCEUS ASIA PARTNERS LP File 021-120021 | $3,254,000 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of the aggregate subscriptions of the Issuer's limited partners during the investment period, and a percentage of invested capital thereafter. | JP Morgan Securities Inc BrokerCheck CRD 79 ↗ | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across all 37 issuers in this group — every filing in our index, latest filing per offering (SEC file number).
0 recorded documents and 0 ownership records matched to Orbimed in the sources searched.
Not found in sources searched as of Oct 24, 2026, 10:16 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026) — 1,263,035 records, loaded Oct 24, 2026, 9:34 AM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.
| Source | Issuer | Linked by | Location | Industry | Filings | Sold (max) | Investors | Min. investment (latest filing) | Active |
|---|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | CA CADUCEUS ASIA PARTNERS LP | shared people, similar issuer names | GEORGE TOWN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 1 | $172,400,000 | 32 | No minimum reported | 2009–2009 |
| EDGAR ↗ | CP Caduceus Private Investments IV, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $312,364,000 | 29 | No minimum reported | 2009–2009 |
| EDGAR ↗ | OP OrbiMed Partners, L.P. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 9 | $128,115,033 offering Indefinite · similar: $155,000–$5,250,000 | 130 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2010–2017 |
| EDGAR ↗ | OP OrbiMed Partners II, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 18 | $1,779,469,650 offering Indefinite · similar: $155,000–$5,250,000 | 880 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2010–2026 |
| EDGAR ↗ | OP OrbiMed Partners, Ltd. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, similar issuer names | ROAD TOWN, TORTOLA, Virgin Islands, British (as filed: D8) | Pooled Investment Fund | 18 | $2,611,956,097 offering Indefinite · similar: $155,000–$5,250,000 | 779 similar: 4–27 | $100,000 similar: $1,000–$100,000 | 2010–2026 |
| EDGAR ↗ | OI OrbiMed Israel Partners Limited Partnership | shared people, shared principal (person on 60+ issuers) at the same address or management entity, similar issuer names, director listed on many unrelated issuers (not used to group) | TEL AVIV, Israel (as filed: L3) | Pooled Investment Fund | 1 | $190,375,000 | 50 | No minimum reported | 2011–2011 |
| EDGAR ↗ | OA OrbiMed Asia Partners II, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $0 | 0 | No minimum reported | 2013–2013 |
| EDGAR ↗ | OG OrbiMed Global Healthcare Fund, Ltd. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, similar issuer names | GRAND CAYMAN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 9 | $988,150,000 offering Indefinite · similar: $155,000–$5,250,000 | 11 similar: 4–27 | $100,000 similar: $1,000–$100,000 | 2013–2021 |
| EDGAR ↗ | OP OrbiMed Private Investments V, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $699,500,000 offering $700,000,000 · similar: $155,000–$5,250,000 | 66 similar: 4–27 | $150,000 similar: $1,000–$100,000 | 2013–2013 |
| EDGAR ↗ | OG OrbiMed Global Healthcare Associates Fund, L.P. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 9 | $17,150,000 offering Indefinite · similar: $155,000–$5,250,000 | 7 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2014–2021 |
| EDGAR ↗ | OG OrbiMed Global Healthcare Fund, L.P. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 8 | $113,350,000 offering Indefinite · similar: $155,000–$5,250,000 | 10 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2014–2021 |
| EDGAR ↗ | OR OrbiMed Royalty Opportunities II, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $900,000,000 offering $900,000,000 · similar: $155,000–$5,250,000 | 83 similar: 4–27 | $750,000 similar: $1,000–$100,000 | 2015–2015 |
| EDGAR ↗ | OP OrbiMed Private Investments VI, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $0 offering $950,000,000 · similar: $155,000–$5,250,000 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2015–2015 |
| EDGAR ↗ | OI OrbiMed Israel Partners II, L.P. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | NEW YORK, NY | Pooled Investment Fund | 1 | $0 offering $300,000,000 · similar: $155,000–$5,250,000 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2015–2015 |
| EDGAR ↗ | OA OrbiMed Asia Partners III, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 4 | $539,960,000 offering $539,960,000 · similar: $155,000–$5,250,000 | 97 similar: 4–27 | $100,000 similar: $1,000–$100,000 | 2017–2017 |
| EDGAR ↗ | OP OrbiMed Private Investments VII, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $0 offering $1,000,000,000 · similar: $155,000–$5,250,000 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2018–2018 |
| EDGAR ↗ | OR OrbiMed Royalty & Credit Opportunities III, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $889,835,000 offering $1,200,000,000 · similar: $155,000–$5,250,000 | 69 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2019–2019 |
| EDGAR ↗ | WH Worldwide Healthcare Partners LLC | shared people, shared management entity, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 9 | $73,761,497 offering Indefinite · similar: $155,000–$5,250,000 | 51 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 | 2019–2025 |
| EDGAR ↗ | EM Emerging Markets Healthcare Partners LLC | shared people, shared management entity, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 9 | $103,744,342 offering Indefinite · similar: $155,000–$5,250,000 | 66 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 | 2019–2025 |
| EDGAR ↗ | VB VANQUA BIO, INC. | shared people, same person name on both filings | CHICAGO, IL | Biotechnology | 3 | $84,999,987 offering $44,979,987 · similar: $2,000,000–$19,999,994 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2019–2024 |
| EDGAR ↗ | OG OrbiMed Genesis Fund, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 7 | $353,340,923 offering Indefinite · similar: $155,000–$5,250,000 | 107 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2019–2025 |
| EDGAR ↗ | OA OrbiMed Asia Partners IV, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $486,882,011 offering $750,000,000 · similar: $155,000–$5,250,000 | 86 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2020–2020 |
| EDGAR ↗ | ON OrbiMed New Horizons Fund, Ltd. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, similar issuer names | GEORGE TOWN, GRAND CAYMAN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 4 | $86,691,450 offering Indefinite · similar: $155,000–$5,250,000 | 29 similar: 4–27 | $100,000 similar: $1,000–$100,000 | 2020–2023 |
| EDGAR ↗ | ON OrbiMed New Horizons Fund, L.P. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 4 | $61,575,000 offering Indefinite · similar: $155,000–$5,250,000 | 55 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2020–2023 |
| EDGAR ↗ | OG OrbiMed Genesis Fund, Ltd. | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, similar issuer names | GEORGE TOWN, GRAND CAYMAN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 7 | $145,947,234 offering Indefinite · similar: $155,000–$5,250,000 | 20 similar: 4–27 | $100,000 similar: $1,000–$100,000 | 2020–2026 |
| EDGAR ↗ | OP OrbiMed Private Investments VIII, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 1 | $0 offering $1,400,000,000 · similar: $155,000–$5,250,000 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2020–2020 |
| EDGAR ↗ | EM Emerging Markets Healthcare Partners International Ltd. | shared people | CAMANA BAY, GRAND CAYMAN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 7 | $3,193,966 offering Indefinite · similar: $155,000–$5,250,000 | 14 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 | 2020–2025 |
| EDGAR ↗ | WH Worldwide Healthcare Partners International Ltd. | shared people, similar issuer names | CAMANA BAY, GRAND CAYMAN, Cayman Islands (as filed: E9) | Pooled Investment Fund | 8 | $1,193,966 offering Indefinite · similar: $155,000–$5,250,000 | 4 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 | 2020–2025 |
| EDGAR ↗ | OR OrbiMed Royalty & Credit Opportunities IV, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $1,153,124,600 offering $1,750,000,000 · similar: $155,000–$5,250,000 | 113 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2022–2022 |
| EDGAR ↗ | OP OrbiMed Private Investments IX, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $1,849,550,000 offering $1,900,000,000 · similar: $155,000–$5,250,000 | 141 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2022–2023 |
| EDGAR ↗ | OA OrbiMed Asia Partners V, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names | New York, NY | Pooled Investment Fund | 2 | $651,872,014 offering $1,100,000,000 · similar: $155,000–$5,250,000 | 68 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2022–2022 |
| EDGAR ↗ | OR OrbiMed RCO IV Offshore Feeder, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | New York, NY | Pooled Investment Fund | 2 | $344,450,400 offering $500,000,000 · similar: $155,000–$5,250,000 | 18 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2022–2022 |
| EDGAR ↗ | BB Belenos Biosciences, Inc. | same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, same business address | NEW YORK, NY | Other | 1 | $48,000,000 offering $55,000,000 · similar: $500,000–$7,000,000 | 2 similar: 2–14 | No minimum reported similar: $5,000–$50,000 | 2024–2024 |
| EDGAR ↗ | OR OrbiMed RCO V Offshore Feeder, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $1,243,525,000 offering $1,750,000,000 · similar: $155,000–$5,250,000 | 31 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2024–2025 |
| EDGAR ↗ | OR OrbiMed Royalty & Credit Opportunities V, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 2 | $1,243,525,000 offering $1,750,000,000 · similar: $155,000–$5,250,000 | 52 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2024–2025 |
| EDGAR ↗ | OP OrbiMed Private Investments X, LP | shared people, shared principal (person on 60+ issuers) at the same address or management entity, shared management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 3 | $1,921,099,472 offering $1,921,099,472 · similar: $155,000–$5,250,000 | 131 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2025–2026 |
| EDGAR ↗ | OA OrbiMed Asia Partners VI, L.P. | shared people, same person name on both filings, shared principal (person on 60+ issuers) at the same address or management entity, same business address, similar issuer names | NEW YORK, NY | Pooled Investment Fund | 3 | $1,045,599,648 offering $1,045,599,648 · similar: $155,000–$5,250,000 | 72 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2025–2026 |
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); Biotechnology / 506(b) (3,253 filings); Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
| Source | Filed | Issuer | Form | Industry | Offered | Sold |
|---|---|---|---|---|---|---|
| EDGAR ↗ | Oct 16, 2026 | OrbiMed Asia Partners VI, L.P. | D/A | Pooled Investment Fund | $1,045,599,648 | $1,045,599,648 |
| EDGAR ↗ | Oct 16, 2026 | OrbiMed Private Investments X, LP | D/A | Pooled Investment Fund | $1,921,099,472 | $1,921,099,472 |
| EDGAR ↗ | Jul 10, 2026 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,779,469,650 |
| EDGAR ↗ | Jul 10, 2026 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,611,956,097 |
| EDGAR ↗ | May 28, 2026 | OrbiMed Asia Partners VI, L.P. | D/A | Pooled Investment Fund | $850,000,000 | $533,984,000 |
| EDGAR ↗ | Apr 30, 2026 | OrbiMed Private Investments X, LP | D/A | Pooled Investment Fund | $1,750,000,000 | $1,669,183,000 |
| EDGAR ↗ | Apr 10, 2026 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $145,947,234 |
| EDGAR ↗ | Dec 5, 2025 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $353,340,923 |
| EDGAR ↗ | Sep 29, 2025 | OrbiMed Asia Partners VI, L.P. | D | Pooled Investment Fund | $850,000,000 | $0 |
| EDGAR ↗ | Sep 29, 2025 | OrbiMed Private Investments X, LP | D | Pooled Investment Fund | $1,750,000,000 | $0 |
| EDGAR ↗ | Aug 18, 2025 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $73,761,497 |
| EDGAR ↗ | Aug 18, 2025 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,193,966 |
| EDGAR ↗ | Aug 18, 2025 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $103,744,342 |
| EDGAR ↗ | Aug 18, 2025 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $3,193,966 |
| EDGAR ↗ | Jul 10, 2025 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,611,956,097 |
| EDGAR ↗ | Jul 10, 2025 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,779,469,650 |
| EDGAR ↗ | May 6, 2025 | OrbiMed Royalty & Credit Opportunities V, LP | D/A | Pooled Investment Fund | $1,750,000,000 | $1,243,525,000 |
| EDGAR ↗ | May 6, 2025 | OrbiMed RCO V Offshore Feeder, LP | D/A | Pooled Investment Fund | $1,750,000,000 | $1,243,525,000 |
| EDGAR ↗ | Apr 11, 2025 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $134,853,571 |
| EDGAR ↗ | Dec 6, 2024 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $338,378,900 |
| EDGAR ↗ | Nov 14, 2024 | OrbiMed Royalty & Credit Opportunities V, LP | D | Pooled Investment Fund | $1,750,000,000 | $0 |
| EDGAR ↗ | Nov 14, 2024 | OrbiMed RCO V Offshore Feeder, LP | D | Pooled Investment Fund | $1,750,000,000 | $0 |
| EDGAR ↗ | Jul 17, 2024 | Belenos Biosciences, Inc. | D | Other | $55,000,000 | $48,000,000 |
| EDGAR ↗ | Jul 12, 2024 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,779,469,650 |
| EDGAR ↗ | Jul 12, 2024 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,611,956,097 |
| EDGAR ↗ | Jul 5, 2024 | VANQUA BIO, INC. | D | Biotechnology | $44,979,987 | $44,979,987 |
| EDGAR ↗ | Jun 7, 2024 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,143,966 |
| EDGAR ↗ | Jun 7, 2024 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $3,093,966 |
| EDGAR ↗ | Jun 7, 2024 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $60,106,406 |
| EDGAR ↗ | Jun 7, 2024 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $95,029,342 |
| EDGAR ↗ | Apr 12, 2024 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $134,748,482 |
| EDGAR ↗ | Dec 8, 2023 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $274,970,000 |
| EDGAR ↗ | Jul 12, 2023 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,779,469,650 |
| EDGAR ↗ | Jul 12, 2023 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,611,956,097 |
| EDGAR ↗ | May 24, 2023 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,143,966 |
| EDGAR ↗ | May 24, 2023 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $3,093,966 |
| EDGAR ↗ | May 24, 2023 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $44,088,402 |
| EDGAR ↗ | May 24, 2023 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $81,529,342 |
| EDGAR ↗ | Apr 28, 2023 | OrbiMed Private Investments IX, LP | D/A | Pooled Investment Fund | $1,900,000,000 | $1,849,550,000 |
| EDGAR ↗ | Apr 14, 2023 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,143,966 |
| EDGAR ↗ | Apr 14, 2023 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $3,093,966 |
| EDGAR ↗ | Apr 14, 2023 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $44,088,402 |
| EDGAR ↗ | Apr 14, 2023 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $81,529,342 |
| EDGAR ↗ | Apr 14, 2023 | OrbiMed New Horizons Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $61,575,000 |
| EDGAR ↗ | Apr 14, 2023 | OrbiMed New Horizons Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $86,691,450 |
| EDGAR ↗ | Apr 14, 2023 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $125,550,001 |
| EDGAR ↗ | Dec 16, 2022 | OrbiMed RCO IV Offshore Feeder, LP | D/A | Pooled Investment Fund | $500,000,000 | $344,450,400 |
| EDGAR ↗ | Dec 16, 2022 | OrbiMed Royalty & Credit Opportunities IV, LP | D/A | Pooled Investment Fund | $1,750,000,000 | $1,153,124,600 |
| EDGAR ↗ | Dec 9, 2022 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $265,425,000 |
| EDGAR ↗ | Nov 28, 2022 | OrbiMed Asia Partners V, L.P. | D/A | Pooled Investment Fund | $1,100,000,000 | $651,872,014 |
| EDGAR ↗ | Jul 14, 2022 | OrbiMed RCO IV Offshore Feeder, LP | D | Pooled Investment Fund | $350,000,000 | $0 |
| EDGAR ↗ | Jul 14, 2022 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,611,956,097 |
| EDGAR ↗ | Jul 14, 2022 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,778,719,650 |
| EDGAR ↗ | Apr 28, 2022 | OrbiMed Private Investments IX, LP | D | Pooled Investment Fund | $1,900,000,000 | $0 |
| EDGAR ↗ | Apr 28, 2022 | OrbiMed Royalty & Credit Opportunities IV, LP | D | Pooled Investment Fund | $1,750,000,000 | $0 |
| EDGAR ↗ | Apr 28, 2022 | OrbiMed Asia Partners V, L.P. | D | Pooled Investment Fund | $1,100,000,000 | $0 |
| EDGAR ↗ | Apr 14, 2022 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $702,365 |
| EDGAR ↗ | Apr 14, 2022 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,652,365 |
| EDGAR ↗ | Apr 14, 2022 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $51,259,670 |
| EDGAR ↗ | Apr 14, 2022 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $82,237,734 |
| EDGAR ↗ | Apr 14, 2022 | OrbiMed New Horizons Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $86,691,450 |
| EDGAR ↗ | Apr 14, 2022 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $100,550,001 |
| EDGAR ↗ | Apr 14, 2022 | OrbiMed New Horizons Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $60,225,000 |
| EDGAR ↗ | Dec 10, 2021 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $184,125,000 |
| EDGAR ↗ | Sep 15, 2021 | VANQUA BIO, INC. | D | Biotechnology | $84,999,987 | $84,999,987 |
| EDGAR ↗ | Jul 16, 2021 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,608,656,097 |
| EDGAR ↗ | Jul 16, 2021 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,770,099,650 |
| EDGAR ↗ | Jul 16, 2021 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $988,150,000 |
| EDGAR ↗ | Jul 16, 2021 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Jul 16, 2021 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Apr 14, 2021 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $702,365 |
| EDGAR ↗ | Apr 14, 2021 | Emerging Markets Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $402,365 |
| EDGAR ↗ | Apr 14, 2021 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $9,500,000 |
| EDGAR ↗ | Apr 14, 2021 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $5,350,000 |
| EDGAR ↗ | Apr 14, 2021 | OrbiMed Genesis Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $29,300,000 |
| EDGAR ↗ | Apr 14, 2021 | OrbiMed New Horizons Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $70,621,000 |
| EDGAR ↗ | Apr 14, 2021 | OrbiMed New Horizons Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $47,325,000 |
| EDGAR ↗ | Dec 11, 2020 | OrbiMed Genesis Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $59,275,000 |
| EDGAR ↗ | Sep 2, 2020 | OrbiMed Asia Partners IV, L.P. | D/A | Pooled Investment Fund | $750,000,000 | $486,882,011 |
| EDGAR ↗ | Sep 1, 2020 | Worldwide Healthcare Partners International Ltd. | D/A | Pooled Investment Fund | Indefinite | $202,365 |
| EDGAR ↗ | Sep 1, 2020 | Worldwide Healthcare Partners International Ltd. | D | Pooled Investment Fund | Indefinite | $202,365 |
| EDGAR ↗ | Sep 1, 2020 | Emerging Markets Healthcare Partners International Ltd. | D | Pooled Investment Fund | Indefinite | $202,365 |
| EDGAR ↗ | Aug 27, 2020 | OrbiMed Private Investments VIII, LP | D | Pooled Investment Fund | $1,400,000,000 | $0 |
| EDGAR ↗ | Jul 16, 2020 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,749,614,118 |
| EDGAR ↗ | Jul 16, 2020 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,520,556,097 |
| EDGAR ↗ | Jul 16, 2020 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $988,150,000 |
| EDGAR ↗ | Jul 16, 2020 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Jul 16, 2020 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Apr 14, 2020 | Worldwide Healthcare Partners LLC | D | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Apr 14, 2020 | Emerging Markets Healthcare Partners LLC | D | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Apr 14, 2020 | OrbiMed Genesis Fund, Ltd. | D | Pooled Investment Fund | Indefinite | $300,000 |
| EDGAR ↗ | Apr 14, 2020 | OrbiMed New Horizons Fund, Ltd. | D | Pooled Investment Fund | Indefinite | $300,000 |
| EDGAR ↗ | Apr 14, 2020 | OrbiMed New Horizons Fund, L.P. | D | Pooled Investment Fund | Indefinite | $25,300,000 |
| EDGAR ↗ | Mar 5, 2020 | OrbiMed Asia Partners IV, L.P. | D | Pooled Investment Fund | $750,000,000 | $0 |
| EDGAR ↗ | Dec 12, 2019 | OrbiMed Genesis Fund, L.P. | D | Pooled Investment Fund | Indefinite | $50,100,000 |
| EDGAR ↗ | Oct 7, 2019 | VANQUA BIO, INC. | D | Other Technology | $18,000,000 | $6,000,000 |
| EDGAR ↗ | Jul 16, 2019 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,511,256,097 |
| EDGAR ↗ | Jul 16, 2019 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,738,864,013 |
| EDGAR ↗ | Jul 16, 2019 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Jul 16, 2019 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $988,150,000 |
| EDGAR ↗ | Jul 16, 2019 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Jul 3, 2019 | OrbiMed Royalty & Credit Opportunities III, LP | D/A | Pooled Investment Fund | $1,200,000,000 | $889,835,000 |
| EDGAR ↗ | Jun 21, 2019 | Worldwide Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Jun 21, 2019 | Emerging Markets Healthcare Partners LLC | D/A | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Jun 4, 2019 | Worldwide Healthcare Partners LLC | D | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Jun 4, 2019 | Emerging Markets Healthcare Partners LLC | D | Pooled Investment Fund | Indefinite | $0 |
| EDGAR ↗ | Jan 29, 2019 | OrbiMed Royalty & Credit Opportunities III, LP | D | Pooled Investment Fund | $1,200,000,000 | $0 |
| EDGAR ↗ | Jul 16, 2018 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,504,925,048 |
| EDGAR ↗ | Jul 16, 2018 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,714,214,013 |
| EDGAR ↗ | Jul 16, 2018 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $982,950,000 |
| EDGAR ↗ | Jul 16, 2018 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Jul 16, 2018 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Jan 30, 2018 | OrbiMed Private Investments VII, LP | D | Pooled Investment Fund | $1,000,000,000 | $0 |
| EDGAR ↗ | Sep 6, 2017 | OrbiMed Asia Partners III, L.P. | D/A | Pooled Investment Fund | $539,960,000 | $539,960,000 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $128,115,033 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,643,696,853 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,440,302,816 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $982,950,000 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Jul 14, 2017 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Jun 28, 2017 | OrbiMed Asia Partners III, L.P. | D/A | Pooled Investment Fund | $450,000,000 | $431,530,000 |
| EDGAR ↗ | Mar 1, 2017 | OrbiMed Asia Partners III, L.P. | D/A | Pooled Investment Fund | $450,000,000 | $0 |
| EDGAR ↗ | Feb 27, 2017 | OrbiMed Asia Partners III, L.P. | D | Pooled Investment Fund | $450,000,000 | $0 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,371,883,805 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,565,361,853 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $127,850,033 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $972,350,000 |
| EDGAR ↗ | Jul 14, 2016 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $113,350,000 |
| EDGAR ↗ | Dec 14, 2015 | OrbiMed Israel Partners II, L.P. | D | Pooled Investment Fund | $300,000,000 | $0 |
| EDGAR ↗ | Sep 15, 2015 | OrbiMed Private Investments VI, LP | D | Pooled Investment Fund | $950,000,000 | $0 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $2,025,279,590 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,346,181,853 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $124,585,033 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $553,750,000 |
| EDGAR ↗ | Jul 14, 2015 | OrbiMed Global Healthcare Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $11,250,000 |
| EDGAR ↗ | Feb 11, 2015 | OrbiMed Global Healthcare Associates Fund, L.P. | D/A | Pooled Investment Fund | Indefinite | $17,150,000 |
| EDGAR ↗ | Feb 2, 2015 | OrbiMed Royalty Opportunities II, LP | D | Pooled Investment Fund | $900,000,000 | $900,000,000 |
| EDGAR ↗ | Oct 15, 2014 | OrbiMed Global Healthcare Fund, Ltd. | D/A | Pooled Investment Fund | Indefinite | $160,000,000 |
| EDGAR ↗ | Jul 14, 2014 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,541,595,970 |
| EDGAR ↗ | Jul 14, 2014 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $1,142,846,853 |
| EDGAR ↗ | Jul 14, 2014 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $117,935,033 |
| EDGAR ↗ | Jul 14, 2014 | OrbiMed Global Healthcare Fund, L.P. | D | Pooled Investment Fund | Indefinite | $6,000,000 |
| EDGAR ↗ | Feb 19, 2014 | OrbiMed Global Healthcare Associates Fund, L.P. | D | Pooled Investment Fund | Indefinite | $600,000 |
| EDGAR ↗ | Nov 5, 2013 | OrbiMed Private Investments V, LP | D | Pooled Investment Fund | $700,000,000 | $699,500,000 |
| EDGAR ↗ | Oct 15, 2013 | OrbiMed Global Healthcare Fund, Ltd. | D | Pooled Investment Fund | Indefinite | $160,000,000 |
| EDGAR ↗ | Aug 15, 2013 | OrbiMed Asia Partners II, LP | D | Pooled Investment Fund | $300,000,000 | $0 |
| EDGAR ↗ | Jul 12, 2013 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,142,381,000 |
| EDGAR ↗ | Jul 12, 2013 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $836,672,000 |
| EDGAR ↗ | Jul 12, 2013 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $112,641,000 |
| EDGAR ↗ | Mar 12, 2013 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $1,033,421,000 |
| EDGAR ↗ | Mar 12, 2013 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $640,107,000 |
| EDGAR ↗ | Mar 12, 2013 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $111,731,000 |
| EDGAR ↗ | Mar 12, 2012 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $446,081,853 |
| EDGAR ↗ | Mar 12, 2012 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $110,685,733 |
| EDGAR ↗ | Mar 12, 2012 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $693,602,073 |
| EDGAR ↗ | Apr 18, 2011 | OrbiMed Israel Partners Limited Partnership | D | Pooled Investment Fund | Indefinite | $190,375,000 |
| EDGAR ↗ | Mar 11, 2011 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $236,139,926 |
| EDGAR ↗ | Mar 11, 2011 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $64,608,125 |
| EDGAR ↗ | Mar 11, 2011 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $156,040,433 |
| EDGAR ↗ | Mar 12, 2010 | OrbiMed Partners, Ltd. | D/A | Pooled Investment Fund | Indefinite | $132,655,433 |
| EDGAR ↗ | Mar 12, 2010 | OrbiMed Partners II, L.P. | D/A | Pooled Investment Fund | Indefinite | $215,514,926 |
| EDGAR ↗ | Mar 12, 2010 | OrbiMed Partners, L.P. | D/A | Pooled Investment Fund | Indefinite | $63,643,125 |
| EDGAR ↗ | Dec 30, 2009 | Caduceus Private Investments IV, LP | D | Pooled Investment Fund | $550,000,000 | $312,364,000 |
| EDGAR ↗ | May 12, 2009 | CADUCEUS ASIA PARTNERS LP | D/A | Pooled Investment Fund | $175,000,000 | $172,400,000 |
Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Oct 16, 2026. Industry history, as reported on each offering's latest filing: Previous offerings: Pooled Investment Fund (2009–2019), Other Technology (2019), Pooled Investment Fund (2019–2020), Biotechnology (2021), Pooled Investment Fund (2022), Biotechnology (2024), Other (2024). Latest offering: Pooled Investment Fund (2024–2025; most recent Sep 29, 2025).
| Name | Roles | Issuers here | First → last listed |
|---|---|---|---|
| CG Carl L. Gordon | Director, Executive Officer, Promoter | 27 | Dec 30, 2009 → Oct 16, 2026 |
| SB Sven H. Borho | Director, Executive Officer, Promoter | 27 | Dec 30, 2009 → Jul 10, 2026 |
| WN W. Carter Neild | Director, Executive Officer, Promoter | 25 | Dec 30, 2009 → Oct 16, 2026 |
| OA OrbiMed Advisors LLC entity | Executive Officer, Promoter | 22 | Dec 30, 2009 → Oct 16, 2026 |
| SI Samuel D. Isaly | Executive Officer, Promoter, Director | 19 | May 12, 2009 → Aug 18, 2025 |
| JS Jonathan T. Silverstein | Executive Officer, Promoter, Director | 19 | Dec 30, 2009 → Jul 5, 2024 |
| GH Geoffrey C. Hsu | Executive Officer | 18 | Mar 11, 2011 → Oct 16, 2026 |
| CS C. Scotland Stevens | Executive Officer | 12 | Jul 16, 2019 → Oct 16, 2026 |
| DB David P. Bonita | Executive Officer | 12 | Apr 14, 2020 → Oct 16, 2026 |
| MR Matthew S. Rizzo | Executive Officer | 9 | Apr 14, 2022 → Oct 16, 2026 |
| PT Peter A. Thompson | Executive Officer | 9 | Apr 14, 2022 → Oct 16, 2026 |
| DW David G. Wang | Director | 5 | Feb 27, 2017 → Oct 16, 2026 |
| SS Sunny Sharma | Director | 4 | Feb 27, 2017 → Oct 16, 2026 |
| BB Brian Burkholder | Director | 4 | Oct 15, 2014 → Jul 10, 2026 |
| MS Michael B. Sheffery | Executive Officer, Promoter | 4 | Dec 30, 2009 → Nov 5, 2013 |
| MA Mona Ashiya | Executive Officer | 3 | Sep 29, 2025 → Oct 16, 2026 |
| DE D. Exome Asset Management LLC entity | Executive Officer | 2 | Apr 14, 2021 → Aug 18, 2025 |
| DE D. Exome Asset GP LLC entity | Executive Officer | 2 | Apr 14, 2021 → Aug 18, 2025 |
| AF Alex R. Forschner | Director | 2 | Jun 7, 2024 → Aug 18, 2025 |
| OR OrbiMed ROF V LLC entity | Executive Officer | 2 | Nov 14, 2024 → May 6, 2025 |
| CG Carlos Manuel Godoy | Director | 2 | Sep 1, 2020 → May 24, 2023 |
| OR OrbiMed ROF IV LLC entity | Executive Officer | 2 | Apr 28, 2022 → Dec 16, 2022 |
| OG OrbiMed Global Healthcare GP LLC entity | Executive Officer | 2 | Feb 19, 2014 → Jul 16, 2021 |
| AN Anat Naschitz | Executive Officer | 2 | Apr 18, 2011 → Dec 14, 2015 |
| ND Nissim Darvish | Executive Officer | 2 | Apr 18, 2011 → Dec 14, 2015 |
| EC Erez Chimovits | Executive Officer | 2 | Apr 18, 2011 → Dec 14, 2015 |
| OA OrbiMed Asia GP VI, L.P. entity | Executive Officer | 1 | Sep 29, 2025 → Oct 16, 2026 |
| OA OrbiMed Advisors VI Limited entity | Executive Officer | 1 | Sep 29, 2025 → Oct 16, 2026 |
| OC OrbiMed Capital GP X, LP entity | Executive Officer | 1 | Sep 29, 2025 → Oct 16, 2026 |
| OC OrbiMed Capital LLC entity | Promoter | 1 | Jul 14, 2015 → Jul 10, 2026 |
| OG OrbiMed Genesis GP LLC entity | Executive Officer | 1 | Dec 12, 2019 → Dec 5, 2025 |
| BC Bo Chen | Director | 1 | Jul 17, 2024 → Jul 17, 2024 |
| TD Tania Dimitrova | Executive Officer | 1 | Jul 17, 2024 → Jul 17, 2024 |
| MD Megan Dow | Executive Officer | 1 | Jul 17, 2024 → Jul 17, 2024 |
| SM StJohn Donnie McGrath | Executive Officer, Director | 1 | Jul 17, 2024 → Jul 17, 2024 |
| JS James Sullivan | Executive Officer, Director | 1 | Oct 7, 2019 → Jul 5, 2024 |
| MA Mona Ashiya | Director | 1 | Oct 7, 2019 → Jul 5, 2024 |
| BD Bernard Davitian | Director | 1 | Sep 15, 2021 → Jul 5, 2024 |
| RS Rand Sutherland | Director | 1 | Jul 5, 2024 → Jul 5, 2024 |
| UC Uya Chuluunbaatar | Director | 1 | Jul 5, 2024 → Jul 5, 2024 |
| OC OrbiMed Capital GP IX LLC entity | Executive Officer | 1 | Apr 28, 2022 → Apr 28, 2023 |
| ON OrbiMed New Horizons GP LLC entity | Executive Officer | 1 | Apr 14, 2020 → Apr 14, 2023 |
| OA OrbiMed Asia GP V, L.P. entity | Executive Officer | 1 | Apr 28, 2022 → Nov 28, 2022 |
| OA OrbiMed Advisors V Limited entity | Executive Officer | 1 | Apr 28, 2022 → Nov 28, 2022 |
| VM Viola Meehan | Executive Officer | 1 | Sep 15, 2021 → Sep 15, 2021 |
| SN Sara Nayeem | Director | 1 | Sep 15, 2021 → Sep 15, 2021 |
| SS Stephen Squinto | Director | 1 | Sep 15, 2021 → Sep 15, 2021 |
| OA OrbiMed Asia GP IV, L.P. entity | Executive Officer, Promoter | 1 | Mar 5, 2020 → Sep 2, 2020 |
| OA OrbiMed Advisors IV Limited entity | Executive Officer, Promoter | 1 | Mar 5, 2020 → Sep 2, 2020 |
| OC OrbiMed Capital GP VIII LLC entity | Executive Officer | 1 | Aug 27, 2020 → Aug 27, 2020 |
| GC Graham B.R. Collis | Director | 1 | Jul 12, 2013 → Jul 16, 2020 |
| OR OrbiMed ROF III LLC entity | Executive Officer | 1 | Jan 29, 2019 → Jul 3, 2019 |
| OC OrbiMed Capital GP VII LLC entity | Executive Officer | 1 | Jan 30, 2018 → Jan 30, 2018 |
| OA OrbiMed Asia GP III, L.P. entity | Executive Officer, Promoter | 1 | Feb 27, 2017 → Sep 6, 2017 |
| OA OrbiMed Advisors III Limited entity | Executive Officer, Promoter | 1 | Feb 27, 2017 → Sep 6, 2017 |
| JW Jonathan Wang | Director | 1 | Feb 27, 2017 → Sep 6, 2017 |
| OI OrbiMed Israel GP II, L.P. entity | Executive Officer, Promoter | 1 | Dec 14, 2015 → Dec 14, 2015 |
| OA OrbiMed Advisors Israel II Limited entity | Executive Officer, Promoter | 1 | Dec 14, 2015 → Dec 14, 2015 |
| OC OrbiMed Capital GP VI LLC entity | Executive Officer | 1 | Sep 15, 2015 → Sep 15, 2015 |
| OR OrbiMed ROF II LLC entity | Executive Officer | 1 | Feb 2, 2015 → Feb 2, 2015 |
3 of 30 issuers (first 30 of 37 issuers checked; each issuer page has its own record) have a matched state registry record — records by status: withdrawn 3.
Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file). A registry listing is the state's own record of the entity; it says nothing about the offering itself.
ORBIMED ADVISORS LLC — SEC-registered investment adviser · SEC registration status as reported: “Approved” since Apr 22, 2002 · SEC file 801-61046 · Main office: NEW YORK, NY · IAPD record ↗ · Form ADV filing (PDF) ↗
Regulatory assets under management: $20,607,970,000 as reported on Form ADV filed Aug 18, 2026 (Item 5.F(2)(c)) · 32 accounts (Item 5.F(2)(f))
Websites listed on Form ADV (Item 1.I): WWW.LINKEDIN.COM/COMPANY/ORBIMED-ADVISORS ↗
Answers as filed by the adviser on Form ADV Part 1A, Item 11; question text quoted from the form. Details of each “Yes” are in the Disclosure Reporting Pages of the Form ADV (PDF) ↗.
Matched on management entity listed on Form D = adviser name, same state (NY) · Form ADV data: SEC Investment Adviser Information Report (SEC-registered advisers), file dated 2026-10-02, loaded Oct 23, 2026, 8:39 PM ET · IAPD record last checked Oct 23, 2026, 8:36 PM ET
No Meta Pixel ids or Facebook / Instagram page links on file for Orbimed as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
No website or social profile named in Orbimed's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #18,136 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
Export this report as PDF · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.
Add a sourced explanation next to any fact. Reviewed before publishing.
One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: NEW YORK), NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.